RMD · 8-K · 20260806PR337962
Capital Return Program
RESMED INC · 2026-08-06 · Importance 75 · Surprise 64 · In source text
ResMed returned $1.0 billion to shareholders through share repurchases and dividends during fiscal 2026, an increase of more than 70% year over year. Fiscal-year share repurchases totaled $700.0 million, compared with $300.0 million in fiscal 2025, and dividends paid totaled $349.7 million. Fourth-quarter dividends and share repurchases returned $287 million to shareholders. ResMed is guiding to more than $1.85 billion of shareholder returns through repurchases and dividends in fiscal 2027.
Key facts
- Guiding to more than $1.85 billion in capital to be returned to shareholders through share repurchases and dividends during FY 2027 source
- Returned $1.0 billion to shareholders through share repurchases and dividends during FY2026, an increase of more than 70% source
- Purchases of treasury stock for twelve months ended June 30, 2026: $(700,037) thousand source
- $287 million returned to shareholders in Q4 through dividends and share repurchases source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -11.2% | Returned $1.0 billion to shareholders through share repurchases and dividends during FY2026, an increase of more than 70% |
| cash | negative | realized | -3.2% | $287 million returned to shareholders in Q4 through dividends and share repurchases |
| cash | negative | probable | — | Guiding to more than $1.85 billion in capital to be returned to shareholders through share repurchases and dividends during FY 2027 |